iBio
IBIO
NZ$1.16
Share price
-2.83%
Change (1 day)
-67.92%
Change (1 year)
Categories
Earnings for iBio (IBIO)
Earnings in 2025 (TTM): -NZ$27.54 Million
According to iBio's latest financial reports the company's current earnings are NZ$0.37 Million. In 2024 the company made an earning of -NZ$23.51 Million, an increase over its 2023 earnings that were of -NZ$34.67 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for iBio from 2008 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | -NZ$27.54 Million | 17.15% |
| 2024 | -NZ$23.51 Million | -32.2% |
| 2023 | -NZ$34.67 Million | -50.39% |
| 2022 | -NZ$69.88 Million | 122.23% |
| 2021 | -NZ$31.45 Million | -12.52% |
| 2020 | -NZ$35.95 Million | 45% |
| 2019 | -NZ$24.79 Million | -3.71% |
| 2018 | -NZ$25.75 Million | 5.52% |
| 2017 | -NZ$24.4 Million | 18.82% |
| 2016 | -NZ$20.54 Million | 60.34% |
| 2015 | -NZ$12.81 Million | 38.31% |
| 2014 | -NZ$9.26 Million | 25.01% |
| 2013 | -NZ$7.41 Million | |
| 2010 | -NZ$20.54 Million | 360.89% |
| 2009 | -NZ$4.46 Million | 5.77% |
| 2008 | -NZ$4.22 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Genocea Biosciences
GNCA | -NZ$62.41 Million | 129.12% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | -NZ$1.52 Million | -94.46% | 🇺🇸 USA |
 Johnson & Johnson JNJ | NZ$45.98 B | -168,951.65% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | -NZ$0.22 Billion | 693.08% | 🇺🇸 USA |